8-K
Current Report
Tempest Therapeutics, Inc. Filed Acc 0001193125-25-085773
Exit or restructuring costs
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading d792758d8k.htm…